National Multiple Sclerosis Society

The National Multiple Sclerosis Society, a United States-based non-profit organization, and its network of chapters nationwide promote research, educate, advocate on issues relating to multiple sclerosis, and organize a wide range of programs, including support for the newly diagnosed and those living with MS. It is headquartered in New York City.

Source: Wikipedia

Campaign Finance

$250 Given
Information

Figures are based on itemized contributions reported to the Federal Election Commission and state agencies. Please note that:

  • contributions under $200 are not reported, and so are not included in totals.
  • only contributions from individuals and organizations to candidates are included. Various accounting measures and more exotic contribution types are excluded.
  • contributions are matched based on organization and recipient name reported within each election cycle. Contributions using an incorrect or non-standard version of the name may be missed.
  • corporate name changes and mergers may cause figures to differ from those of the Center for Responsive Politics.
  • organization totals include known subsidiaries of the organization.

For more information, please see our campaign finance methodology page. Lobbyist bundling data is described on our lobbyist bundling methodology page.

covers through Q3 2012

  • Top Recipients

    Employee Color Block
    Individuals
    PAC Color Block
    PAC
    Includes contributions from the organization’s employees, their family members, and its political action committee.

  • Republicans vs. Democrats

    in dollars

  • State vs. Federal

    in dollars
View all campaign finance data for National Multiple Sclerosis Society Sources: OpenSecrets.org

Lobbying

$779,577 Spent
Information

Figures are based on lobbying activity reported to the Senate Office of Public Records. Reported dollar amounts are required to be accurate only to the nearest $20,000. For organizations whose primary business is lobbying, we display total income and top clients. For organizations that are not primarily lobbying firms, we display total amount spent on lobbying and top lobbying firms hired.

For more information, please see our lobbying methodology page.

covers roughly through Q3, 2012

Lobbying on Behalf of National Multiple Sclerosis Society

  • Names of Lobbyists
  • Firm Hired Amount
    National Multiple Sclerosis Society $779,577
  • Most Frequently Disclosed Lobbying Issues
    • Fed Budget & Appropriations,
    • Health Issues,
    • Medicare & Medicaid,
    • Civil Rights & Civil Liberties
  • Most Frequently Disclosed Bills
    Bill No. Title
    S.597 A bill to amend title XVIII of the Social Security Act to include neurologists as primary care physicians for purposes of incentive payments for primary care services under the Medicare program.
    H.R.2224 Improving Physician Access in Teaching Hospitals (PATH) Act of 2011
    H.R.1055 Part D Off-Label Prescription Parity Act
    H.R.833 Agricultural Export Enhancement Act of 2011
    S.365 Budget Control Act of 2011
    S.425 National Neurological Diseases Surveillance System Act of 2011
    S.495 Adult Day Achievement Center Enhancement Act
    H.R.2219 Department of Defense Appropriations Act, 2012
    H.R.2595 National Neurological Diseases Surveillance System Act of 2011
    H.R.3266 Lifespan Respite Care Reauthorization Act of 2011
View all lobbying data for National Multiple Sclerosis Society Sources: OpenSecrets.org

Regulations

Mentioned in 27 dockets; Submitted to 1 docket
Information

All data is based on documents downloaded from Regulations.gov. The first table shows mentions: all documents that include the name of the company anywhere in the document or document metadata. The second table shows submissions: all documents where the submitter metadata included the company name. Each table shows the top 10 dockets, ranked by number of occurrences.

Matches are based on a search for the company name. Variations in the company name, such as acronyms, nicknames or alternate names may cause documents to be missed. The mention of a company name in a document may be incidental and does not necessarily indicate that the company has any relevance to the document. Company names that are common English words may erroneously match with text that is not referring to the company.

Not all agencies submit public comments to Regulations.gov. For a list of participating and non-participating agencies see here. Agencies that do submit to Regulations.gov have varying levels of accuracy and completeness.

Regulations and public comments can be downloaded in bulk here.

updated daily from Regulations.gov by way of Docket Wrench

The tables show occurrences of "National Multiple Sclerosis Society" in public comments on proposed federal regulations.